BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SVACS - ECPv6.15.1.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SVACS
X-ORIGINAL-URL:https://www.siliconvalleyacs.org
X-WR-CALDESC:Events for SVACS
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20221020T110000
DTEND;TZID=America/Los_Angeles:20221020T120000
DTSTAMP:20260425T211829
CREATED:20221004T003809Z
LAST-MODIFIED:20221004T193604Z
UID:19176-1666263600-1666267200@www.siliconvalleyacs.org
SUMMARY:Creating Psychedelic Analogs to Treat Neuropsychiatric Disease
DESCRIPTION:Prof. David Olson\, Department of Chemistry\, Department of Biochemistry & Molecular Medicine\, UC Davis\nSponsored by ACS Webinars\, ACS Publications\, ACS Division of Medicinal Chemistry\, and American Association of Pharmaceutical Scientists\n11am-Noon\, Online via Zoom\, Free\, Registration required\n\nWe are at an exciting moment in drug discovery due to the enormous potential of psychedelics and related plasticity-promoting neurotherapeutics to treat common\, but highly debilitating conditions such as schizophrenia\, bipolar disorder\, major depressive disorder\, and attention deficit hyperactivity disorder. \nJoin Associate Professor Dr. David Olson of UC Davis as he discusses how psychedelics and related molecules\, such as DMT\, LSD\, and MDMA\, rapidly promote the growth of cortical neurons\, providing a potential explanation for their long-lasting therapeutic effects after a single dose. Register now to discover about the development of chemical and molecular tools for studying the mechanisms of action of psychedelics as well as efforts to engineer non-hallucinogenic analogs of these compounds that produce similar sustained therapeutic behavioral effects after a single administration. \nThis ACS Webinar is moderated by Editor-in-Chief Dr. Christa Müller of ACS Pharmacology & Translational Science co-produced with the ACS Division of Medicinal Chemistry\, and ACS Publications. \n\n\n\nWhat You Will Learn\n\nMechanistic details about psychedelic-induced neuroplasticity\nThe development of a novel biosensor for assessing hallucinogenic potential\nThe development of non-hallucinogenic psychoplastogens\n\n\n\n\n\n\n\nWebinar Details\n\nThrusday\, October 20\, 2022 @ 2-3pm ET\nFree to Register with ACS ID\nSlides will be available to download on the day of the webinar
URL:https://www.siliconvalleyacs.org/event/creating-psychedelic-analogs-to-treat-neuropsychiatric-disease/
LOCATION:Virtual
CATEGORIES:ACS Webinars
ATTACH;FMTTYPE=image/jpeg:https://www.siliconvalleyacs.org/wp-content/uploads/2022/10/Creating-psychedelic-analogs-ACS-webinar.jpg
END:VEVENT
END:VCALENDAR